Problems with drug-eluting coronary stents--the FDA perspective
- PMID: 15483274
- DOI: 10.1056/NEJMp048262
Problems with drug-eluting coronary stents--the FDA perspective
Similar articles
-
Stent thrombosis redux--the FDA perspective.N Engl J Med. 2007 Mar 8;356(10):984-7. doi: 10.1056/NEJMp068304. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296827 No abstract available.
-
Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Coron Artery Dis. 2010. PMID: 19952925 Review.
-
The turmoil around the drug-eluting stents.Scand Cardiovasc J. 2007 Jun;41(3):131-2. doi: 10.1080/14017430701308851. Scand Cardiovasc J. 2007. PMID: 17487758 No abstract available.
-
Stent thrombosis in randomized clinical trials of drug-eluting stents.N Engl J Med. 2007 Mar 8;356(10):1020-9. doi: 10.1056/NEJMoa067731. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296821
-
The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.Cardiol Rev. 2006 May-Jun;14(3):143-50. doi: 10.1097/01.crd.0000214683.72810.87. Cardiol Rev. 2006. PMID: 16628023 Review.
Cited by
-
Targeted thrombolysis strategies for neuroprotective effect.Neural Regen Res. 2014 Jul 1;9(13):1316-22. doi: 10.4103/1673-5374.137580. Neural Regen Res. 2014. PMID: 25221585 Free PMC article.
-
Simulating complex patient populations with hierarchical learning effects to support methods development for post-market surveillance.BMC Med Res Methodol. 2023 Apr 11;23(1):89. doi: 10.1186/s12874-023-01913-9. BMC Med Res Methodol. 2023. PMID: 37041457 Free PMC article.
-
Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights.Nat Rev Cardiol. 2015 Jun;12(6):325-36. doi: 10.1038/nrcardio.2015.32. Epub 2015 Mar 17. Nat Rev Cardiol. 2015. PMID: 25781415 Review.
-
Clinical impact of the gap-angle ratio in patients with ostial lesions of the right coronary artery undergoing percutaneous coronary intervention.Heart Vessels. 2019 Nov;34(11):1717-1727. doi: 10.1007/s00380-019-01417-x. Epub 2019 Apr 26. Heart Vessels. 2019. PMID: 31028408
-
Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.Biomaterials. 2008 Apr;29(11):1676-85. doi: 10.1016/j.biomaterials.2007.12.015. Epub 2008 Jan 14. Biomaterials. 2008. PMID: 18192005 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical